ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Lawmakers in the House of Representatives last week passed legislation (H.R. 4250) that would require FDA to review applications for new sunscreen ingredients within 11 months. It would also require FDA to clear the current backlog of sunscreen applications within eight months. Introduced in March by Rep. Ed Whitfield (R-Ky.), the bill is being welcomed by the Public Access to SunScreens Coalition, a group of medical professionals, skin cancer experts, and sunscreen manufacturers. The coalition has long been pushing FDA to accelerate the approval of new sunscreen technologies, claiming that several ingredients awaiting approval in the U.S. have been widely available in Europe and other parts of the world, in some cases for more than a decade. The Senate is expected to vote on companion legislation (S. 2141) in September.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X